US Stock MarketDetailed Quotes

LYRA Lyra Therapeutics

Watchlist

0.183
+0.001+0.77%

Trading Nov 22 14:56 ET

12.00MMarket Cap-123P/E (TTM)

Lyra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lyra Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 204.800K	--
--	2024/Q3	195.000K / 245.000K	--
--	2024/Q2	598.000K / 346.200K	--
--	2024/Q1	532.000K / 345.830K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 204.800K--

--2024/Q3195.000K / 245.000K--

--2024/Q2598.000K / 346.200K--

--2024/Q1532.000K / 345.830K--

Unlock Free Earnings Estimates

Open Account

Lyra Therapeutics Earnings Reports

Lyra Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 12 16:30 ET

Lyra Therapeutics | 8-K: Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 12 16:25 ET

Lyra Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 14 16:29 ET

Lyra Therapeutics | 8-K: Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 14 16:16 ET

Analyst Rating

Updated: Nov 22, 2024

Hold

Buy
0.00%
Hold
100.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall